Showing results (221-230 of 264) with videos related to

Sort By:
Pageof 27
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 20, 2003
On the prophylactic and therapeutic use of danaparoid sodium (Orgaran) in patients with heparin-induced thrombocytopeniaJoachim F Schenk, Gerhard Pindur, Bernhard Stephan, et al.
Molecular Biology and Evolution|May 17, 2013
Patterns of Epistasis between beneficial mutations in an antibiotic resistance geneMartijn F Schenk, Ivan G Szendro, Merijn L M Salverda, et al.
Seminars in Thrombosis and Hemostasis|May 18, 1999
Training of patients for self-management of oral anticoagulant therapy: standards, patient suitability, and clinical aspectsS Mörsdorf, W Erdlenbruch, U Taborski, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1979
Isolation of the opioid heptapeptide Met-enkephalin [Arg6,Phe7] from bovine adrenal medullary granules and striatumA S Stern, R V Lewis, S Kimura, et al.
FEBS Letters|January 26, 1987
Chromogranin A can act as a reversible processing enzyme inhibitor. Evidence from the inhibition of the IRCM-serine protease 1 cleavage of pro-enkephalin and ACTH at pairs of basic amino acidsN G Seidah, G N Hendy, J Hamelin, et al.
The Journal of Cell Biology|September 1, 1991
Targeting of frog prodermorphin to the regulated secretory pathway by fusion to proenkephalinG Seethaler, M Chaminade, R Vlasak, et al.
Nature|May 9, 2000
Identification of sleep-promoting neurons in vitroT Gallopin, P Fort, E Eggermann, et al.
Melanoma Research|September 14, 2000
Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cellsA J Schrader, M Probst-Kepper, J Grosse, et al.
Thrombosis Research|January 11, 2001
Platelet activation and its role in thrombin generation in platelet-induced thrombin generation timeP Radziwon, B Boczkowska-Radziwon, J F Schenk, et al.
European Journal of Pharmacology|October 7, 1986
3-(Methoxycarbonyl)-amino-beta-carboline, a selective antagonist of the sedative effects of benzodiazepinesL Prado de Carvalho, P Venault, M C Potier, et al.
Pageof 27